Adcock Ingram Holdings Limited

Adcock Ingram Holdings Limited, headquartered in ZA and operating in the Pharmaceutical Preparation Manufacturing industry, reported its total carbon emissions for 2024 as approximately 131.47 million kg CO2e. This figure represents the sum of their Scope 1, Scope 2, and Scope 3 emissions.

For 2024, the company's Scope 1 emissions were approximately 17.23 million kg CO2e. Scope 2 emissions, primarily from purchased electricity, amounted to about 52.56 million kg CO2e. Scope 3 emissions, including categories such as business travel, employee commute, purchased goods and services, waste generated in operations, fuel and energy-related activities, and upstream transportation and distribution, were approximately 63.53 million kg CO2e.

In 2023, Adcock Ingram Holdings Limited reported total emissions of about 134.03 million kg CO2e, with Scope 1 emissions at approximately 21.22 million kg CO2e and Scope 3 emissions at about 60.33 million kg CO2e. While specific Scope 2 data for 2023 was not disclosed, their combined Scope 1 and 2 emissions (market-based) for that year were approximately 73.70 million kg CO2e.

The company has not publicly disclosed any specific reduction targets or climate pledges, nor does it have Science Based Targets initiative (SBTi) commitments. No cascaded emissions data or targets from a parent or related organisation were identified.